Cite
HARVARD Citation
Austin, C. et al. (2020). A randomized, placebo‐controlled trial evaluating effects of lebrikizumab on airway eosinophilic inflammation and remodelling in uncontrolled asthma (CLAVIER). Clinical & experimental allergy. 50 (12), pp. 1342-1351. [Online].